https://www.selleckchem.com/products/dnqx.html
Among propensity-matched cohorts (n=25 each), 5-year relapse-free survival rates were 77.6% in the SPSHD group and 49.9% in the splenectomy group. Laparoscopic SPSHD can potentially replace prophylactic splenectomy. Laparoscopic SPSHD can potentially replace prophylactic splenectomy. Gastric cancer patients are often transfused with red blood cells, with negative impact on postoperative course. This multicenter prospective interventional cohort study aimed to determine whether implementation of a Patient Blood Management (PBM) program, was